Yeping began his professional career as an assistant professor of Biochemical Engineering at Tsinghua University (Beijing, China). Before he founded Climax, he was working as a director of DMPK at Limerick Biopharma, Inc. , and a principal research scientist in DMPK at Roche Pharmaceuticals. Prior to Roche, Yeping was the director of DMPK at Galileo Pharmaceuticals, and associate director of DMPK at Exelixis. Yeping has also worked with Corixa and Sugen as a scientist for years. Yeping has been a reviewer of NSF and the journal of pharmaceutical and biomedical analysis since 1997. He has been a member of the advisory council at San Jose Biocenter since 2008. He also served as a judge of the Intel International Science and Technology Fair in 2001 and 2009. Yeping has more than 30 publications as the first author. Yeping was granted the "2008 Excellence in Sciences Award" from the American Society for Small Molecule Science and Amgen. Yeping has been an advisory member of SPARK program at School of Medicine, Stanford University since 2009.
Yeping received master degrees from Long Island University (New York) and Chinese Academy of Sciences.Yeping obtained his Ph.D. in Bioanalytical and Pharmaceutical Chemistry from the University of Kansas. He did his post-doctoral training in Biopharmaceutical Sciences at University of California San Francisco.
Yeping Zhao, Ph.D.